Dog /

Breed profile · FDA CVM July 2026 extract

Spaniel - Springer (unspecified) adverse-event record

Adverse-event filings for Spaniel - Springer (unspecified) (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#113 of 510
by report volume (all breeds)
983
FDA CVM reports on file
5.2%
death-coded share of reports
#120 of 275
by death-coded share (≥50 reports)

How the 983 reports break down

By recorded gender -- every report on file for Spaniel - Springer (unspecified), no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 66 49.5 33 16.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Spaniel - Springer (unspecified) drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Spaniel - Springer (unspecified) ranks #113 of 510 by total reports (983) and #120 of 275 by death-coded share (5.2%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#113
This breed, reports of 510
#120
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Spaniel - Springer (unspecified) has 983 reports now versus 971 in that prior snapshot: 12 more (1.2%).

Report change
+12
Death-coded reports
+2
Death-coded share
+0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Spaniel - Springer (unspecified) changes

Total Reports

983

High report volume

Deaths Reported

51

of 983 reports

Death-coded share of reports

5.2%

Above-median death-coded share

Avg Age at Report

6.3 yr

21.2 kg avg weight

Breed Safety Scorecard

F (32/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate D
5.2%

Share of reports coded as a fatality

Euthanasia rate D
2.4%

Share of reports resulting in euthanasia

Full recovery rate F
22.8%

Share of reports coded "Recovered/Normal"

5-year trend F
+83%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Spaniel - Springer (unspecified) death-coded reports 5.2%
Cross-breed median

5.2% of 983 spaniel - springer (unspecified) reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Spaniel - Springer (unspecified)'s death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

5% 56th percentile Higher share than 56% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Spaniel - Springer (unspecified) 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 21.2 kg (46.7 lbs)

Top Reported Reactions

Vomiting 169
Lack of efficacy - NOS 64
INEFFECTIVE, HEARTWORM LARVAE 62
Diarrhoea 61
Lack of efficacy (ectoparasite) - flea 61
Emesis 59
Lack of efficacy (endoparasite) - hookworm 58
Lethargy (see also Central nervous system depression in 'Neurological') 55

Most Referenced Drugs

Milbemycin Oxime + Spinosad 201
Milbemycin Oxime + Praziquantel 77
Spinosad 76
Pyrantel Pamoate;Sarolaner 76
Oclacitinib Maleate 55
Carprofen 51
Ivermectin, Pyrantel 50
Moxidectin 46

Outcome Breakdown

Recovered/Normal
224 (31.4%)
Outcome Unknown
212 (29.7%)
Ongoing
209 (29.3%)
Died
27 (3.8%)
Euthanized
24 (3.4%)
Recovered with Sequela
17 (2.4%)

Gender Distribution

Female 514 (52.3%)
Male 457 (46.5%)
Unknown 11 (1.1%)
Mixed 1 (0.1%)

Reports by Year

Year Reports Trend
2010 137
2011 117
2012 63
2013 62
2014 56
2015 50
2016 66
2017 39
2018 32
2019 43
2020 46
2021 36
2022 54
2023 49
2024 58
2025 66
2026 9

Spaniel - Springer (unspecified): high-volume FDA adverse-event cohort

Signature read: 983 reports place Spaniel - Springer (unspecified) in the upper third of breed filing volume (#113 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Spaniel - Springer (unspecified) sits at #113 of 510 by report volume among all breeds and #94 of 298 among dog breeds, with 983 reports and 51 (5.2%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #120 of 275. Mean age at report: 6.3 years, average weight 21.2 kg (46.7 lbs).

Top reported signs: Vomiting (169), Lack of efficacy - NOS (64), INEFFECTIVE, HEARTWORM LARVAE (62). Most-referenced drug: Milbemycin Oxime + Spinosad (201 reports), followed by Milbemycin Oxime + Praziquantel (77) and Spinosad (76).

Outcome coding on 713 status-recorded reports is dominated by Recovered/Normal (31.4%). Annual submissions ranged 9-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Spaniel - Springer (unspecified) drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (5.2% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (21.2 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Spaniel - Springer (unspecified)?
There are 983 adverse event reports involving Spaniel - Springer (unspecified) in the FDA database, of which 51 were death-coded (5.2% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Spaniel - Springer (unspecified) ranks #113 of 510 by report volume among all breeds PlainBreed indexes (#94 of 298 among dog breeds).
Where does Spaniel - Springer (unspecified) sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Spaniel - Springer (unspecified) is #113 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #94 of 298. Among breeds with at least 50 reports, its death-coded share ranks #120 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Spaniel - Springer (unspecified)?
The most commonly reported adverse reactions for Spaniel - Springer (unspecified) are Vomiting (169 reports), Lack of efficacy - NOS (64 reports), INEFFECTIVE, HEARTWORM LARVAE (62 reports), Diarrhoea (61 reports), Lack of efficacy (ectoparasite) - flea (61 reports).
What drugs are most frequently associated with Spaniel - Springer (unspecified) adverse events?
The drugs most frequently referenced in Spaniel - Springer (unspecified) adverse event reports are Milbemycin Oxime + Spinosad (201 reports), Milbemycin Oxime + Praziquantel (77 reports), Spinosad (76 reports), Pyrantel Pamoate;Sarolaner (76 reports), Oclacitinib Maleate (55 reports).
What is the average age of Spaniel - Springer (unspecified) in adverse event reports?
The average age of Spaniel - Springer (unspecified) at the time of adverse event reports is 6.3 years, with an average weight of 21.2 kg (46.7 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Spaniel - Springer (unspecified) (Dog), extract as of July 2026 extract. 983 reports · 51 death-coded (5.2% of reports, not a mortality rate) · #113 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →